chr18-44953350-T-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015559.3(SETBP1):​c.4000+10T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.118 in 1,609,664 control chromosomes in the GnomAD database, including 12,937 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1047 hom., cov: 32)
Exomes 𝑓: 0.12 ( 11890 hom. )

Consequence

SETBP1
NM_015559.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.586

Publications

12 publications found
Variant links:
Genes affected
SETBP1 (HGNC:15573): (SET binding protein 1) This gene encodes a protein which contains a several motifs including a ski homology region and a SET-binding region in addition to three nuclear localization signals. The encoded protein has been shown to bind the SET nuclear oncogene which is involved in DNA replication. Mutations in this gene are associated with Schinzel-Giedion midface retraction syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
SETBP1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal dominant 29
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Schinzel-Giedion syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • intellectual disability-expressive aphasia-facial dysmorphism syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 18-44953350-T-A is Benign according to our data. Variant chr18-44953350-T-A is described in ClinVar as Benign. ClinVar VariationId is 159877.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.209 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SETBP1NM_015559.3 linkc.4000+10T>A intron_variant Intron 4 of 5 ENST00000649279.2 NP_056374.2 Q9Y6X0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SETBP1ENST00000649279.2 linkc.4000+10T>A intron_variant Intron 4 of 5 NM_015559.3 ENSP00000497406.1 Q9Y6X0-1

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15757
AN:
152076
Hom.:
1034
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0418
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.113
Gnomad EAS
AF:
0.181
Gnomad SAS
AF:
0.114
Gnomad FIN
AF:
0.0835
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.112
Gnomad OTH
AF:
0.114
GnomAD2 exomes
AF:
0.139
AC:
34156
AN:
245482
AF XY:
0.134
show subpopulations
Gnomad AFR exome
AF:
0.0384
Gnomad AMR exome
AF:
0.316
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.186
Gnomad FIN exome
AF:
0.0770
Gnomad NFE exome
AF:
0.111
Gnomad OTH exome
AF:
0.131
GnomAD4 exome
AF:
0.120
AC:
174169
AN:
1457470
Hom.:
11890
Cov.:
33
AF XY:
0.119
AC XY:
86625
AN XY:
725188
show subpopulations
African (AFR)
AF:
0.0373
AC:
1247
AN:
33416
American (AMR)
AF:
0.301
AC:
13408
AN:
44520
Ashkenazi Jewish (ASJ)
AF:
0.119
AC:
3113
AN:
26112
East Asian (EAS)
AF:
0.191
AC:
7567
AN:
39676
South Asian (SAS)
AF:
0.121
AC:
10441
AN:
86042
European-Finnish (FIN)
AF:
0.0745
AC:
3932
AN:
52806
Middle Eastern (MID)
AF:
0.133
AC:
765
AN:
5764
European-Non Finnish (NFE)
AF:
0.114
AC:
126562
AN:
1108892
Other (OTH)
AF:
0.118
AC:
7134
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
7580
15159
22739
30318
37898
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4766
9532
14298
19064
23830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15795
AN:
152194
Hom.:
1047
Cov.:
32
AF XY:
0.106
AC XY:
7886
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0418
AC:
1738
AN:
41554
American (AMR)
AF:
0.215
AC:
3281
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
391
AN:
3472
East Asian (EAS)
AF:
0.181
AC:
933
AN:
5154
South Asian (SAS)
AF:
0.114
AC:
552
AN:
4824
European-Finnish (FIN)
AF:
0.0835
AC:
885
AN:
10604
Middle Eastern (MID)
AF:
0.129
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
0.112
AC:
7621
AN:
67984
Other (OTH)
AF:
0.118
AC:
250
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
695
1390
2085
2780
3475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0706
Hom.:
102
Bravo
AF:
0.114
Asia WGS
AF:
0.182
AC:
634
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 45% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 42. Only high quality variants are reported. -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Schinzel-Giedion syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
13
DANN
Benign
0.65
PhyloP100
-0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3786177; hg19: chr18-42533315; COSMIC: COSV56314030; API